ATG-017

ATG-017 · Antengene Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATG-017, covering 2024-07-23 to 2024-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies [Phase 1]

See pricing